Evidence map›Paper›PMID 35296853›Full record

ArticleNature2022

Activation mechanism of the class D fungal GPCR dimer Ste2.

Vaithish Velazhahan, Ning Ma, Nagarajan Vaidehi, Christopher G Tate

Open access · hybridAbstract read
In one paragraph

Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. GPCR Heterodimers: Implications for Biased Signaling.Handbook of experimental pharmacology · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Vaithish VelazhahanMRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge, UK.
Ning MaDepartment of Computational and Quantitative Medicine, Beckman Research Institute of the City of Hope, Duarte, CA, USA.
Nagarajan VaidehiDepartment of Computational and Quantitative Medicine, Beckman Research Institute of the City of Hope, Duarte, CA, USA.ORCID http://orcid.org/0000-0001-8100-8132
Christopher G TateMRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge, UK. cgt@mrc-lmb.cam.ac.uk.ORCID http://orcid.org/0000-0002-2008-9183
City of Hope · USMRC Laboratory of Molecular Biology · GB

Funding

Structural dynamics underlying GPCR-G protein selectivityR01GM117923 · NIGMS · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI VAIDEHI, NAGARAJAN · 2017 to 2024
$3.8M
Medical Research Council MC_U105197215Medical Research Council U105107215MRF_ MRF-110-057-S-RADA-C0940NIGMS NIH HHS R01 GM117923
6 · The paper itself

Abstract

The fungal class D1 G-protein-coupled receptor (GPCR) Ste2 has a different arrangement of transmembrane helices compared with mammalian GPCRs and a distinct mode of coupling to the heterotrimeric G protein Gpa1-Ste2-Ste18

Indexed as

GTP-Binding Protein gamma SubunitsHeterotrimeric GTP-Binding ProteinsSaccharomyces cerevisiae ProteinsAnimalsCell MembraneMammalsReceptors, G-Protein-CoupledReceptors, Mating FactorSaccharomyces cerevisiaeGTP-Binding Protein gamma SubunitsHeterotrimeric GTP-Binding ProteinsReceptors, G-Protein-CoupledReceptors, Mating FactorSaccharomyces cerevisiae ProteinsSTE18 protein, S cerevisiaeSTE2 protein, S cerevisiae

Identifiers

PMID35296853
PMCPMC8942848
OpenAlexW4221062442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.